Rockefeller Capital Management
CTSO icon

Rockefeller Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Rockefeller Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05K Sell
1,861
-705
-27% -$481 ﹤0.01% 4482
2025
Q4 		$1.64K Buy
2,566
+1,566
+157% +$1.21K ﹤0.01% 4367
2025
Q3 		$934 Buy
+1,000
New +$985 ﹤0.01% 4195

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Rockefeller Capital Management's CTSO Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Cytosorbents Corp (CTSO) stake by 27% in Q1 2026, selling an estimated $481 and leaving 1,861 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #4482.

Rockefeller Capital Management first reported a position in CTSO in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.64K in Q4 2025. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Rockefeller Capital Management held 1,861 shares of Cytosorbents Corp worth $1.05K as of Q1 2026.
  • Rockefeller Capital Management sold 705 Cytosorbents Corp shares in Q1 2026, an estimated $481.
  • Cytosorbents Corp made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4482 holding.
  • Rockefeller Capital Management first reported a position in Cytosorbents Corp in Q3 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's Cytosorbents Corp position peaked at $1.64K in Q4 2025.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.